PROCEDE DE SYNTHESE ET INTERMEDIAIRES DE BENZOXATHIEPINES
    2.
    发明公开
    PROCEDE DE SYNTHESE ET INTERMEDIAIRES DE BENZOXATHIEPINES 有权
    合成方法和BENZOXATHIEPINZWISCHENPRODUKTE

    公开(公告)号:EP1735297A1

    公开(公告)日:2006-12-27

    申请号:EP05753693.0

    申请日:2005-04-08

    IPC分类号: C07D327/02 C07C323/22

    CPC分类号: C07D327/02 C07C323/52

    摘要: The invention relates to preparing derivatives of formula (1), wherein, in particular R1 and R2, identical or different, represent a hydrogen, fluorine or chlorine atom, a hydroxy group, an alkyl radical and an alkoxy radical, R3 is an alkyl radical, a hydroxy group or a methoxy radical, R4 is a hydrogen atom or a methyl radical and R5 and R6, identical or different, represent a hydrogen atom, an alkyl radical, an alkoxy radical, an alkylthio radical and an alkylamino radical. The inventive method consists in reducing an amid of formula (9).

    NOUVEAUX DERIVES D'ARYL-4-HALOGENO-4- HETEROARYLMETHYLAMINO)-METHYL]-PIPERIDIN-1-YL-METHANONE,LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENTS
    3.
    发明公开
    NOUVEAUX DERIVES D'ARYL-4-HALOGENO-4- HETEROARYLMETHYLAMINO)-METHYL]-PIPERIDIN-1-YL-METHANONE,LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENTS 有权
    NOUVEAUX衍生物D'ARYL-4-卤代戊酸4-杂芳基甲基氨基) - 甲基] - 哌啶-1-基 - 甲酮,LEUR方法和制备方法以及使用的药物

    公开(公告)号:EP1539738A1

    公开(公告)日:2005-06-15

    申请号:EP03760060.8

    申请日:2003-06-18

    CPC分类号: C07D401/12

    摘要: The invention relates to compounds of general formula (1) in which X and Y = a carbon with a bonded hydrogen atom (CH) or a nitrogen atom, A = a methyl, fluoromethyl, cyano, hydroxyl, methoxy group, or a chlorine or fluorine atom on condition that when A = methyl (CH3) and X and Y both = a carbon bonded to a hydrogen atom, then B = a chlorine atom, B = a chlorine or a fluorine atom, D = a hydrogen, chlorine, fluorine atom, or a cyano or trifluoromethyl group and E = a hydrogen, fluorine or chlorine atom.

    摘要翻译: 本发明涉及通式(1)的化合物,其中X和Y =具有键合的氢原子(CH)或氮原子的碳,A =甲基,氟甲基,氰基,羟基,甲氧基或氯或 当A =甲基(CH3)且X和Y均为=与氢原子键合的碳时,则B =氯原子,B =氯或氟原子,D =氢,氯,氟 原子或氰基或三氟甲基,E =氢,氟或氯原子。

    DERIVES BENZOAXATHIEPINES ET LEUR UTILISATION COMME MEDICAMENTS
    4.
    发明授权
    DERIVES BENZOAXATHIEPINES ET LEUR UTILISATION COMME MEDICAMENTS 有权
    BENZOAXATHIEPIN衍生物及其医药用途

    公开(公告)号:EP1370547B1

    公开(公告)日:2004-09-15

    申请号:EP02759802.8

    申请日:2002-03-20

    CPC分类号: C07C323/22 C07D327/02

    摘要: The invention concerns 3-arylthio-propyl-amino-3,4-dihydro-2H-1,5-aryloxathiepin derivatives of general formula (I), wherein: R1 and R2, identical or different, represent a hydrogen atom, a fluorine atom or a chlorine atom, a hydroxy group, an alkyl, cyclopropyl, alkoxy, cyclopropoxy radical or when they occupy adjacent positions, form with the carbon atoms bearing them a carbon-containing cycle or an oxygen-containing heterocycle with five non-aromatic rings; R3 represents an alkyl radical, a hydroxy group or a methoxy radical; R4 represents a hydrogen atom or a methyl radical; and R5 and R6, identical or different represent a hydrogen atom, an alkyl, alkoxy, alkylthio, alkylamino radical, or the groups OR4 and R5 form with the carbons which bear them a non-aromatic heterocycle with five or six rings containing at least an oxygen atom; and their pharmaceutically acceptable additions salts.

    DERIVES BENZOAXATHIEPINES ET LEUR UTILISATION COMME MEDICAMENTS
    8.
    发明公开
    DERIVES BENZOAXATHIEPINES ET LEUR UTILISATION COMME MEDICAMENTS 有权
    BENZOAXATHIEPIN衍生物及其医药用途

    公开(公告)号:EP1370547A1

    公开(公告)日:2003-12-17

    申请号:EP02759802.8

    申请日:2002-03-20

    CPC分类号: C07C323/22 C07D327/02

    摘要: The invention concerns 3-arylthio-propyl-amino-3,4-dihydro-2H-1,5-aryloxathiepin derivatives of general formula (I), wherein: R1 and R2, identical or different, represent a hydrogen atom, a fluorine atom or a chlorine atom, a hydroxy group, an alkyl, cyclopropyl, alkoxy, cyclopropoxy radical or when they occupy adjacent positions, form with the carbon atoms bearing them a carbon-containing cycle or an oxygen-containing heterocycle with five non-aromatic rings; R3 represents an alkyl radical, a hydroxy group or a methoxy radical; R4 represents a hydrogen atom or a methyl radical; and R5 and R6, identical or different represent a hydrogen atom, an alkyl, alkoxy, alkylthio, alkylamino radical, or the groups OR4 and R5 form with the carbons which bear them a non-aromatic heterocycle with five or six rings containing at least an oxygen atom; and their pharmaceutically acceptable additions salts.